简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

Sanuwave Health预计第三季度收入在1140万美元至1160万美元之间

2025-10-07 04:10

  • Sanuwave Health (NASDAQ:SNWV) announced on Monday that its revenues for the third quarter of 2025 are expected to be in the range of $11.4 to $11.6 million versus consensus of $12.37 million, an increase of 22% to 24% over Q3 2024. However, the revenue is below the $12-$12.7 million range of guidance given in the company’s Q2 2025 earnings release.
  • “Q3 turned out to be a more challenging quarter than we expected,” said CEO Morgan Frank. “The wound care space has had quite a lot of uncertainty around the proposed reimbursement changes for certain treatment modalities, particularly skin substitutes/grafts. This uncertainty seems to have frozen the market a bit, particularly early in the quarter. Purchase decisions were delayed and patient counts reduced as providers seemed to take a ‘wait and see’ approach to potential changes. This made for a difficult environment. All in all, I think the team did well to achieve 12-14% sequential growth during this period and 22-24% vs the ‘pig through a python’ quarter last year.
  • "Despite the headwinds, we sold a record number of systems in the quarter. That said, we fell short of our target and of our guidance (the first time this has happened in my tenure as CEO). The quarter started slowly, and we simply could not make up the ground, despite ending on a high note with September being the highest revenue month in Sanuwave history. That said, based on the performance in Q3, we feel it prudent at this time to alter our 2025 annual revenue guidance from $48-$50 million to $44-$46 million," added Frank.
  • SNWV +0.42% after hours to $40.842.
  • Source: Press Release

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号